Organigram to Announce Q2 Fiscal 2025 Results on May 12

OrganiGram Holdings ( (TSE:OGI) ) just unveiled an announcement.

Organigram Global Inc. announced it will release its second quarter fiscal 2025 earnings results on May 12, 2025. The company will host a conference call to discuss these results, with a webcast replay available for 90 days. This announcement is significant as it provides insights into Organigram’s financial performance and strategic positioning within the competitive cannabis market.

Spark’s Take on TSE:OGI Stock

According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.

OrganiGram Holdings faces significant financial challenges, with ongoing profitability issues and negative cash flows. However, strong market share growth and strategic expansions provide some optimism. Technical indicators suggest caution, and the valuation is currently unattractive due to negative earnings. Strategic management of costs and cash flow is critical for improving stock performance. The earnings call adds a positive note with expected operational improvements and market expansion.

To see Spark’s full report on TSE:OGI stock, click here.

More about OrganiGram Holdings

Organigram Global Inc. is a leading cannabis company in Canada, listed on NASDAQ and TSX. It focuses on producing high-quality cannabis for adult recreational use and expanding its global presence through international partnerships. The company has a diverse portfolio of cannabis brands and operates multiple facilities in Canada, including those optimized for extraction, formulation, and national fulfillment.

YTD Price Performance: -31.33%

Average Trading Volume: 870,052

Technical Sentiment Signal: Buy

Current Market Cap: $144.2M

Find detailed analytics on OGI stock on TipRanks’ Stock Analysis page.